Upregulation of Coagulation Factor VIII and Fibrinogen After Pulmonary Endarterectomy in Patients with Chronic Thromboembolic Pulmonary Hypertension.
Lasse MyllylahtiJussi RopponenMikko LaxRiitta LassilaAntti I NykänenPublished in: Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis (2023)
FVIII is elevated in most patients with CTEPH. After PEA, early but transient elevation of FVIII and fibrinogen, and delayed reactive thrombocytosis, occurs, and warrants careful postoperative anticoagulation to prevent thromboembolism recurrence.
Keyphrases
- pulmonary hypertension
- atrial fibrillation
- pulmonary artery
- pulmonary arterial hypertension
- patients undergoing
- poor prognosis
- venous thromboembolism
- cell proliferation
- coronary artery bypass grafting
- cerebral ischemia
- signaling pathway
- free survival
- coronary artery disease
- blood brain barrier
- long non coding rna
- percutaneous coronary intervention
- subarachnoid hemorrhage